XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Organization (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Feb. 12, 2018
Aug. 31, 2018
Jul. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Subsidiary, Sale of Stock [Line Items]            
Sale of stock, offering price (in usd per share) $ 12.00 $ 20.00        
Proceeds from initial public offering, net of underwriters fees $ 56,300     $ 67,700    
Common stock, shares authorized (in shares) 100,000,000     100,000,000   100,000,000
Common stock, par value (in dollars per share) $ 0.00001     $ 0.00001   $ 0.00001
Preferred stock, shares authorized (in shares) 10,000,000     10,000,000   10,000,000
Preferred stock, par value (in dollars per share) $ 0.00001     $ 0.00001   $ 0.00001
Number of shares sold upon completion of follow-on public offering (in shares)     3,600,000      
Net loss       $ (10,975) $ (6,162)  
Cash used in operations       (19,200) $ (2,201)  
Cash and cash equivalents       54,367   $ 93,162
Short-term investments       79,313   0
Accumulated deficit       $ 134,000   $ 123,025
ALPHAEON | Evolus, Inc.            
Subsidiary, Sale of Stock [Line Items]            
Ownership percentage       56.00%    
IPO            
Subsidiary, Sale of Stock [Line Items]            
Number of shares issued in transaction (in shares) 5,047,514          
Underwriters Option            
Subsidiary, Sale of Stock [Line Items]            
Number of shares issued in transaction (in shares) 47,514          
Number of shares sold upon completion of follow-on public offering (in shares)   600,000        
Common Stock | IPO            
Subsidiary, Sale of Stock [Line Items]            
Number of shares sold upon completion of follow-on public offering (in shares)         5,047,514  
Common Stock | Convertible Preferred Stock            
Subsidiary, Sale of Stock [Line Items]            
Number of shares of convertible preferred stock converted (in shares) 2,065,875